Last reviewed · How we verify

NCT04329871

Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance

Status unknown Last updated 2 April 2020
What this trial tests

trial in Type 1 Diabetes Mellitus in 100 participants. Status unknown.

Timeline
24 March 2020
Primary endpoint
23 March 2021
23 March 2021

Quick facts

Lead sponsorMetabolic Research Institute, Inc.
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date24 March 2020
Primary completion23 March 2021
Estimated completion23 March 2021
Sites1 location across United States

Conditions studied

Sponsor

Metabolic Research Institute, Inc.

Who can join

18 and older, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Analyze the Medtronic 670g pump on glycemic control

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes Mellitus

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04329871.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing